Nursing

Difficult Access Requires Thought, Training and Technology (DART3): Co-developing an ultrasound pathway for patients with difficult intravenous access

NHMRC partnership project grant 2019 (Award ID:1180193)

Exploring Infection Risk Factors and Infection Prevention and Control Interventions for Acute Hospital Inpatients with Behavioural Disturbance, Secondary to Cognitive Dysfunction, substance use or psychosocial disadvantage

The Prince Charles Hospital Foundation PhD Scholarship 2025

The Threshold for Platelets study: a prospective randomised trial to define the platelet count which critically ill patients should receive a platelet transfusion prior to an invasive procedure

Medical Research Future Fund – Clinical Trials Activity Initiative – 2023 International Clinical Trial Collaborations Grant Opportunity Round 1 (Award ID: 2031827)

REBUILD: Reducing the Burden of Healthcare Associated Infection Using a Learning Health Systems Approach

NHMRC 2024 Collaborations in Health Services Research

Just Say No to the Just in Case Cannula: An Implementation Science Trial

Medical Research Future Fund (MRFF) - Externally led by Monash University

Translating Healthcare-Associated Infection Prevention Research into Practice: Australian Hospitals Survey 2025

Health care associated infection burden in Queensland, Australia

Queensland Government

Mortality, length of stay, and cost attributable to CRBSI and CLABSI in patients with a central venous catheter in an Australian tertiary hospital: a case-control study

Comparative effectiveness of Class II/III medical devices to prevent bloodstream infections in central venous access devices: The IVCare adaptive platform trial (IVCare)

National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451)

Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial)

Becton, Dickinson and Company; Herston Infectious Diseased Institute (HeIDI)